Li HY, Wu JZ, Wu JL, Pang Y, Jiang CY, Qin L, Wei KL. Association between HLA-DRB1*11/14 alleles and HBV-related liver diseases.
Shijie Huaren Xiaohua Zazhi 2012;
20:2672-2677. [DOI:
10.11569/wcjd.v20.i28.2672]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the association between HLA-DRB1*11/14 alleles and hepatitis B virus (HBV)-related diseases in the Guangxi population.
METHODS: A total of 320 patients with HBV infection and 150 normal control subjects were included in this study. The frequencies of HLA-DRB1* 11/14 alleles were measured by polymerase chain reaction/sequence specific primer (PCR/SSP).
RESULTS: The frequency of the HLA-DRB1*11 allele in patients with liver cirrhosis was markedly higher than that in the normal control group (18.9% vs 7.3%, P = 0.007, OR = 0.340). The frequencies of the HLA-DRB1*14 allele in chronic asymptomatic hepatitis B virus carriers, patients with chronic hepatitis B, liver cirrhosis, or hepatocellular carcinoma were all higher than that in the normal control group (36.0% vs 19.3%, 30.7% vs 19.3%, 32.2% vs 19.3%, 35.0% vs 19.3%; P = 0.016, 0.025, 0.024, 0.035, OR = 0.426, 0.541, 0.504, 2.247).
CONCLUSION: The HLA-DRB1*11 allele is associated with susceptibility to liver cirrhosis, and the HLA-DRB1*14 allele is associated with susceptibility to chronic asymptomatic hepatitis B, chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma in patients with HBV infection.
Collapse